HuMab-5B1 (MVT-5873)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HuMab-5B1 (MVT-5873), covering 2025-01-28 to 2025-01-28. Get the full timeline:
Most recent: Clinical Trial Update: Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies [Phase 1]